// company-profile

NextCure, Inc.

NXTC
ExchangeNasdaqSectorPharmaceutical PreparationsInc.DEFilings52Insiders16
// api This NextCure, Inc. insider-trading data is served live by the Form4API insider trading API. Get the same data via API.

// activity-summary

Recent insider activity is bullish. Over the last 30 days, 6 insiders purchased shares. Buying was led by Feigal Ellen.

// 90-day insight

Over the last 90 days, NextCure, Inc. insiders bought $0 across 6 transactions with no open-market sales.

  • Most active insider: Feigal Ellen with 1 transaction totaling $0.

Activity skews bullish — buys outpace sales.

Institutional Ownership

Top 13F-HR holders of NextCure, Inc. as of 2026-03-31

↓ decreasing
Total reported AUM
$21.1M
QoQ change
-19.4%
Reporting period
2026-03-31
#1
Squadron Capital Management LLC
CIK 2050709
$2.8M
265K shares
#2
Affinity Asset Advisors, LLC
CIK 1773195
$2.6M
242K shares
#3
Ikarian Capital, LLC
CIK 1778253
$2.5M
238K shares

Data source: SEC Form 13F-HR filings. Joined with insider activity above — see who's loading up institutionally while insiders are trading. Full 13F-HR API →

Insider Transactions

Sourced from SEC EDGAR Form 4 filings. Updated hourly.

DateInsiderCompanyTypeSharesPriceValue
Jun 18, 2026Feigal EllenNXTC
Award
2,340$0.00$0K
Jun 18, 2026Jones Elaine VNXTC
Award
2,340$0.00$0K
Jun 18, 2026Webster Stephen WNXTC
Award
2,340$0.00$0K
Jun 18, 2026KABAKOFF DAVID SNXTC
Award
3,510$0.00$0K
Jun 18, 2026Houston John GNXTC
Award
2,340$0.00$0K

45 more transactions hidden

Free account · No credit card required

Building something? Get API access →

Popular companies on Form4API

Browse insider trading activity for other actively-filed companies.